IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,944,000 | -32.2% | 373,148 | +21.4% | 0.01% | -33.3% |
| Q3 2016 | $7,287,000 | -16.8% | 307,477 | +1.2% | 0.01% | -18.2% |
| Q2 2016 | $8,755,000 | -1.7% | 303,791 | +9.2% | 0.01% | -8.3% |
| Q1 2016 | $8,905,000 | -23.0% | 278,093 | +2.9% | 0.01% | -20.0% |
| Q4 2015 | $11,559,000 | +22.0% | 270,323 | +0.5% | 0.02% | +15.4% |
| Q3 2015 | $9,472,000 | -24.5% | 269,010 | -1.5% | 0.01% | -18.8% |
| Q2 2015 | $12,543,000 | +6.1% | 273,155 | +8.3% | 0.02% | +6.7% |
| Q1 2015 | $11,821,000 | +49.6% | 252,201 | +1.1% | 0.02% | +50.0% |
| Q4 2014 | $7,904,000 | +32.6% | 249,485 | -0.8% | 0.01% | +25.0% |
| Q3 2014 | $5,961,000 | -20.3% | 251,424 | +0.8% | 0.01% | -20.0% |
| Q2 2014 | $7,479,000 | +5.2% | 249,371 | -7.4% | 0.01% | 0.0% |
| Q1 2014 | $7,112,000 | +6.3% | 269,191 | +1.1% | 0.01% | 0.0% |
| Q4 2013 | $6,693,000 | +20.4% | 266,234 | -2.0% | 0.01% | +11.1% |
| Q3 2013 | $5,559,000 | +3.3% | 271,563 | +0.6% | 0.01% | -10.0% |
| Q2 2013 | $5,381,000 | – | 269,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |